Cargando…
Current Standards and Recent Advances in Biomarkers of Major Endocrine Tumors
The complexity of endocrine tumor diagnosis stems from its variable symptoms and presentation that may mimic many other disease states, or display asymptomatic properties for a prolonged amount of time. Early and accurate disease identification is needed for better patient prognosis. The key to this...
Autores principales: | Luo, Yanhong, Zhu, Hua, Tan, Tao, He, Jianfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139354/ https://www.ncbi.nlm.nih.gov/pubmed/30250431 http://dx.doi.org/10.3389/fphar.2018.00963 |
Ejemplares similares
-
Advances in the Molecular Genetics of Catecholaminergic Polymorphic Ventricular Tachycardia
por: Song, Junxia, et al.
Publicado: (2021) -
Ferroptosis and Tumor Drug Resistance: Current Status and Major Challenges
por: Nie, Zhenyu, et al.
Publicado: (2022) -
Recent Advance of Nanomaterial-Mediated Tumor Therapies in the Past Five Years
por: Hao, Xinyan, et al.
Publicado: (2022) -
Recent Advances in the Role of Autophagy in Endocrine-Dependent Tumors
por: Komarla, Anvita, et al.
Publicado: (2023) -
Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers
por: He, Luying, et al.
Publicado: (2022)